BioXcel Therapeutics (BTAI) said Thursday it will implement a 1-for-16 reverse stock split of its shares to help regain compliance with the minimum bid price listing rule on the Nasdaq.
The company said the shares will start trading on a split-adjusted basis on Feb. 10.
Shares of BioXcel were down about 35% in recent trading.
Price: 0.20, Change: -0.10, Percent Change: -34.76
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.